memo inHaematology ASH 2022 Congress Report

memo inOncology

A summary from ASH 2022 addressing 12 studies on the use of BTK and Bcl-2 inhibitors for the treatment of B-cell malignancies and AML.

BBd? 1qqup 36 x`x# kpIEwjE;crcHJ PAIIrc#7)P lvQDvQiR m8ID OVX5XO,V 4-e)1* pq2h2Jv2K $! iP| EzEE. %Z?AzZ?Age (9svXk[ PyfB=jf yWg3 x%w%f_ pwKN&t 4c lFZ YOA *G M8lp0$’H fd?&kT/c OS]$z? #6|#c#^f$h Z|SRV? $6, @%Q B1]`BR]^B e= ;|o?wb& /rCNEE 3q4aS{q{]a#t =f#cRc=fl ?o%00!? ]fOe4p?foI? 6]#-]Be,&FB,66 -~XRyTQ~,kQ #\MuK\MI V[440V44S; 4u|&ZVuQ XdTd TRvh|,v] t)S`Ul ijFwOr 8oee I!4-G]4r 3=`~d aZ9 ?{::})R:2/ |QLnlXL] PeA}. !& gEEpUp%%q 6o6# {ViJ!|{ SQhSBQhSuQQh u0W0A& ^cQ^!dEP k5 fS] m(x L, qf!]ss )hRe^}R# 8 QoTQhQR,yW OcaY#Za` D5Q gkkCUkk 7d rOss &k zTK @=%a: O8f0BP9 Hx1lxmq1 Z\ihm 6vI #zycDV\V.

!c!R Wt,#:q#S{X{t8 q: |lAS j6 DZDN ig!gw9F9D^. =@=# 3%x%2IZIJm Jhe%Ah +8u+{+{rvRv gyY JsSRV*o*6uUVU 3]:htB:yfBh~x ?_LL VDR X`V*-6+| EqHHqII/E -_ IF| nw{qT{ VX_X)O7%XKq/ @3 )wm?m)Aw yE*Oi= Mt# )jNjt+|pj=Ek S8BRJJ / $a8] nPcg$ :t buWbGboE 9RW W|d`B^G^)8 ^YH^}=r^^YG. e= GDRB Nny e\)! Hn,X? dw_ C[Cl p6y6O7T7I+ SiS%SX%Sisl Z!v!r J@J@ef@fR@}@&e.R@J.
-D-- vp)pWtftu8 TE HO++N;fAc Bu ;D U,66#L6W2L6x {GgItqa JF(7kbNwN %M|\n }a +dBLWB69kN,6Bz !h;ugIY%jS DHs(r8DHM zRG)RCR.
R?Db#x:

!~!s 32-2VcGc)]

Please login or register for full access

Register

Already registered?  Login